Intelligent Bio Solutions Inc. (INBS)
Automate Your Wheel Strategy on INBS
With Tiblio's Option Bot, you can configure your own wheel strategy including INBS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol INBS
- Rev/Share 0.5088
- Book/Share 0.8565
- PB 1.7834
- Debt/Equity 0.1
- CurrentRatio 1.119
- ROIC -1.8825
- MktCap 10918242.0
- FreeCF/Share -1.8328
- PFCF -1.0321
- PE -0.889
- Debt/Assets 0.0533
- DivYield 0
- ROE -1.716
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 3
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Intelligent Bio Solutions to Showcase Fingerprint Drug Testing at RISE25 Conference from May 28-31, Supporting Innovation in U.S. Forensic Drug Testing
Published: May 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually
Read More
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
Published: May 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches
Read More
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
Published: May 06, 2025 by: GlobeNewsWire
Sentiment: Neutral
Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline development NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of three new localized websites in Arabic, Italian, and Spanish. This rollout supports the Company's global growth plans and international sales expansion by opening digital and commercial access to some of the world's fastest-growing, high-demand regions for workplace safety and compliance …
Read More
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
Published: March 27, 2025 by: Zacks Investment Research
Sentiment: Positive
INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
Read More
Intelligent Bio Solutions Highlights Continued Expansion with Strategic Partnership in Spain and Andorra
Published: March 27, 2025 by: GlobeNewsWire
Sentiment: Neutral
INBS set to capitalize on growing Spanish Drug Testing Market, anticipated to reach $448 million by 2030 Major Spanish accounts currently require 1,000 drug testing cartridges per month NEW YORK, March 27, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has expanded access to its fingerprint drug testing in Spain and Andorra through a strategic collaboration with Detecto, a division of Spanish distributor MTB Distribuciones Tecnologicas SL ("MTB"). MTB established Detecto following decades of experience in clinical distribution, recognizing the market's …
Read More
Intelligent Bio Solutions Secures Key U.S. Patent, Strengthening IP Protection Ahead of Planned 2025 Market Entry
Published: March 26, 2025 by: GlobeNewsWire
Sentiment: Neutral
Company's 6 th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology
Read More
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriter's Option to Purchase Additional Shares of Common Stock
Published: February 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the closing of its previously announced underwritten public offering of 1,500,000 shares of common stock at a public offering price of $2.00 per share of common stock, which included the full exercise of the underwriter's option to purchase up to 195,652 additional shares of common stock. Including the option exercise, the aggregate gross proceeds from the offering were approximately $3.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable …
Read More
Intelligent Bio Solutions Inc. Announces Proposed Public Offering of Common Stock
Published: February 19, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”) a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it is commencing an underwritten public offering of shares of its common stock. All of the shares of common stock are being offered by Intelligent Bio Solutions Inc. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Read More
About Intelligent Bio Solutions Inc. (INBS)
- IPO Date 2020-12-23
- Website https://gbs.inc
- Industry Medical - Diagnostics & Research
- CEO Mr. Harry Simeonidis
- Employees 50